乌鸦传媒

<乌鸦传媒 class="page-title">Clinical Challenges

ASH: DLBCL and CLL

<乌鸦传媒 class="page-description">American Society of Hematology

More in ASH: DLBCL and CLL

Clinical Challenges: Treating CLL When BTK Inhibition Fails

Strategies for patients who progress and those intolerant of ibrutinib

Dec 11, 2018
image

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis